Spots Global Cancer Trial Database for pembrolizumab dose b
Every month we try and update this database with for pembrolizumab dose b cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555) | NCT03665597 | Melanoma | Pembrolizumab D... Pembrolizumab D... Pembrolizumab D... Pembrolizumab D... | 18 Years - | Merck Sharp & Dohme LLC |